Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes of genetic testing in adults with a history of venous thromboembolism.

Evidence report/technology assessment - 1 Jun 2009

Segal Jodi B, Brotman Daniel J, Emadi Ashkan, Necochea Alejandro J, Samal Lipika, Wilson Lisa M, Crim Matthew T, Bass Eric B

Abstract excerpt

OBJECTIVE: To address whether Factor V Leiden (FVL) testing alone, or in combination with prothrombin G20210A testing, leads to improved clinical outcomes in adults with a personal history of venous thromboembolism (VTE) or to improved clinical outcomes in adult family members of mutation-positive individuals. DATA SOURCES: Searches of MEDLINE, EMBASE, The Cochrane Library, the Cumulative Index to Nursing and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Genetic Markers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Mutation

Share to Prothrombin

Share to Randomized Controlled Trials as Topic

Share to Treatment Outcome

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 20629476
PMCID: PMC4781326

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes of genetic testing in adults with a history of venous thromboembolism.PMID 20629476Read ↗

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.Semantic proximity Read ↗

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Semantic proximity Read ↗

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relativesSemantic proximity Read ↗

Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Semantic proximity Read ↗

Molecular diagnostics of inherited thrombosis.Semantic proximity Read ↗

Social and ethical controversies in thrombophilia testing and update on genetic risk factors for venous thromboembolism.Semantic proximity Read ↗

Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.Semantic proximity Read ↗

Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes.Semantic proximity Read ↗

Family history and inherited thrombophilia.Semantic proximity Read ↗

Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A.Semantic proximity Read ↗

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Semantic proximity Read ↗

Factor V Leiden thrombophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.